Participants:0–17 years · 18–64 years
Substances:Modified Mrna Encoding Human Methylmalonyl-Coenzyme A Mutase Containing A Polymorphism At Position 671

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

Registered drug

The Netherlands

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Osteogenesis imperfecta

Not recruiting

Investigational

Study on Setrusumab for Patients with Osteogenesis Imperfecta (Brittle Bone Disease)

Investigational

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Setrusumab

Contact Research Centre

Propionic acidaemia

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Codeine Phosphate

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Sjogren's syndrome

Not recruiting

Registered drug

Study on Leflunomide and Hydroxychloroquine for Patients with Primary Sjögren's Syndrome

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Leflunomide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Factor IX deficiency

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Efficacy of Etranacogene Dezaparvovec for Adults with Severe or Moderately Severe Hemophilia B

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Etranacogene Dezaparvovec

Contact Research Centre

Escherichia urinary tract infection

Not recruiting

Investigational

Study of ExPEC9V vaccine for preventing invasive E.

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ecoo15

Contact Research Centre

Find therapies in clinical trials near you – page 43

616 trials match your criteria

Diffuse large B-cell lymphoma+2

Study of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Chronic lymphocytic leukaemia

Study of Acalabrutinib for Patients with Chronic Lymphocytic Leukemia

Chronic myeloid leukaemia+2

Study on the Dose and Safety of Asciminib in Children with Chronic Myeloid Leukemia

Methylmalonic acidaemia

Study on mRNA-3705 for Patients with Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency

Dermatitis atopic

Study on Amlitelimab for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Using Topical Corticosteroids and Inadequate Response to Previous Treatments

Osteogenesis imperfecta

Study on Setrusumab for Patients with Osteogenesis Imperfecta (Brittle Bone Disease)

Propionic acidaemia

Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia

Non-small cell lung cancer

Study of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation

Sjogren's syndrome

Study on Leflunomide and Hydroxychloroquine for Patients with Primary Sjögren's Syndrome

Non-small cell lung cancer

Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Factor IX deficiency

Study on Long-Term Safety and Efficacy of Etranacogene Dezaparvovec for Adults with Severe or Moderately Severe Hemophilia B

Escherichia urinary tract infection

Study of ExPEC9V vaccine for preventing invasive E.

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.